Mark A. Hillman
Hillman Value Fund
Hillman Value Fund Portfolio 13F
Mark A. Hillman Holdings Activity
- Portfolio value:
- $131.62M≈ (+$28M≈)
- Previous value:
- $103.80M≈
- # of changes:
- 18
- New positions:
- 1
- Reported for:
- 31 Dec 2020 (Q4)
- Latest filing date:
- 25 Feb 2021
Hillman Value Fund has disclosed a total of 18 changes to the portfolio in the (2020 Q4) SEC report(s): increased the number of shares of 15, bought 1 totally new, decreased the number of shares of 1 and completely sold out 1 position(s).
What stocks did Mark A. Hillman buy in 2020 Q4?
During 2020 Q4 Mark A. Hillman has bought 16 securities out of which top 5 purchases (by % change to portfolio) were (WFC) Wells Fargo & Company (added shares +17.42%), (JPM) JPMorgan Chase & Co (added shares +22.00%), (PAA) Plains All American Pipeline LP (added shares +18.39%), (MRK) Merck & Company Inc (added shares +54.95%) and (XOM) Exxon Mobil Corp (added shares +27.06%).
18 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BANK OF NEW YORK MELLON CORP
|
new
|
$42.44
|
+264.88%($154.86)
|
3.22%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
Merck & Company Inc
|
+54.95%
|
$81.80
|
+55.77%($127.42)
|
3.51%
|
2020 Q1
|
≈ 1.00 year
|
||||
|
|
Kraft Heinz Co
|
+31.87%
|
$34.66
|
-24.45%($26.18)
|
3.16%
|
2020 Q1
|
≈ 1.00 year
|
||||
|
|
Enterprise Products Partners LP
|
+29.09%
|
$19.59
|
+91.78%($37.57)
|
3.17%
|
2020 Q1
|
≈ 1.00 year
|
||||
|
|
AT&T Inc
|
+27.18%
|
$28.76
|
-18.36%($23.48)
|
2.86%
|
2020 Q1
|
≈ 1.00 year
|
||||
|
|
Exxon Mobil Corp
|
+27.06%
|
$41.22
|
+276.20%($155.07)
|
3.38%
|
2020 Q1
|
≈ 1.00 year
|
||||
|
|
RTX Corp
|
+26.51%
|
$71.51
|
+202.22%($216.12)
|
3.37%
|
2020 Q2
|
≈ 0.75 years
|
||||
|
|
CVS Health Corp
|
+26.00%
|
$68.30
|
+54.14%($105.28)
|
3.27%
|
2020 Q1
|
≈ 1.00 year
|
||||
|
|
Verizon Communications Inc
|
+24.32%
|
$58.75
|
-19.43%($47.34)
|
2.85%
|
2020 Q1
|
≈ 1.00 year
|
||||
|
|
Pfizer Inc
|
+22.09%
|
$36.81
|
-32.25%($24.94)
|
2.78%
|
2020 Q1
|
≈ 1.00 year
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.